These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 1590420)
21. Impaired hepatic apolipoprotein B and E translation in streptozotocin diabetic rats. Sparks JD; Zolfaghari R; Sparks CE; Smith HC; Fisher EA J Clin Invest; 1992 May; 89(5):1418-30. PubMed ID: 1533230 [TBL] [Abstract][Full Text] [Related]
22. Nephrotic hyperlipidemia: primary abnormalities in both lipoprotein catabolism and synthesis. Kaysen GA Miner Electrolyte Metab; 1992; 18(2-5):212-6. PubMed ID: 1465061 [TBL] [Abstract][Full Text] [Related]
23. Excessive cholesterolemic response in analbuminemic rats fed a cholesterol-rich diet containing casein. Zhang X; Joles JA; Koomans HA; van Tol A; Beynen AC J Nutr; 1992 Mar; 122(3):520-7. PubMed ID: 1542009 [TBL] [Abstract][Full Text] [Related]
24. Apolipoprotein AI and apolipoprotein E mRNA expression in peripheral white blood cells from patients with orthotopic liver transplantation. Martínez-López E; Nuño-González P; Ruiz-Madrigal B; Rodríguez-Sancho LC; Hernández-Nazará ZH; Segura-Ortega JE; Panduro A Liver Int; 2007 Sep; 27(7):930-7. PubMed ID: 17696931 [TBL] [Abstract][Full Text] [Related]
25. Endothelial chylomicron binding is altered by interaction with high-density lipoprotein in Heymann's nephritis. Shearer GC; Couser WG; Kaysen GA Am J Kidney Dis; 2001 Dec; 38(6):1385-9. PubMed ID: 11728980 [TBL] [Abstract][Full Text] [Related]
26. Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI. Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo. Ginsberg HN; Le NA; Goldberg IJ; Gibson JC; Rubinstein A; Wang-Iverson P; Norum R; Brown WV J Clin Invest; 1986 Nov; 78(5):1287-95. PubMed ID: 3095375 [TBL] [Abstract][Full Text] [Related]
27. Hyperlipoproteinemia in one-year-old analbuminemic rats. Joles JA; Willekes-Koolschijn N; van Tol A; Geelhoed-Mieras MM; Danse LH; van Garderen E; Kortlandt W; Erkelens DW; Koomans HA Atherosclerosis; 1991 May; 88(1):35-47. PubMed ID: 1878008 [TBL] [Abstract][Full Text] [Related]
28. Plasma composition in the nephrotic syndrome. Kaysen GA Am J Nephrol; 1993; 13(5):347-59. PubMed ID: 8116687 [TBL] [Abstract][Full Text] [Related]
29. Effects of gemfibrozil and ketoconazole on human apolipoprotein AI, B and E levels in two hepatoma cell lines, HepG2 and Hep3B. Tam SP Atherosclerosis; 1991 Nov; 91(1-2):51-61. PubMed ID: 1811554 [TBL] [Abstract][Full Text] [Related]
30. Proteinuria decreases tissue lipoprotein receptor levels resulting in altered lipoprotein structure and increasing lipid levels. Wang L; Shearer GC; Budamagunta MS; Voss JC; Molfino A; Kaysen GA Kidney Int; 2012 Nov; 82(9):990-9. PubMed ID: 22785171 [TBL] [Abstract][Full Text] [Related]
31. Hypercholesterolemia induced by cholesterol- or cystine-enriched diets is characterized by different plasma lipoprotein and apolipoprotein concentrations in rats. Sérougne C; Felgines C; Férézou J; Hajri T; Bertin C; Mazur A J Nutr; 1995 Jan; 125(1):35-41. PubMed ID: 7815174 [TBL] [Abstract][Full Text] [Related]
32. Lipid synthesis and apolipoprotein gene expression in hepatocytes in primary culture from (puromycin-induced) nephrotic rats. el Boustani S; Ribeiro A; Janvier B; Loriette C; Bensman R; Druet P; Chambaz J; Mangeney M Eur J Clin Invest; 1993 Apr; 23(4):211-8. PubMed ID: 8500513 [TBL] [Abstract][Full Text] [Related]
33. Effects of hormone replacement therapy and hepatic lipase polymorphism on serum lipid profiles in postmenopausal Japanese women. Somekawa Y; Umeki H; Kobayashi K; Tomura S; Aso T; Hamaguchi H J Clin Endocrinol Metab; 2002 Oct; 87(10):4766-70. PubMed ID: 12364471 [TBL] [Abstract][Full Text] [Related]
34. Effects of gender on hepatic HMG-CoA reductase, cholesterol 7alpha-hydroxylase, and LDL receptor in hereditary analbuminemia. Shin Y; Vaziri ND; Willekes N; Kim CH; Joles JA Am J Physiol Endocrinol Metab; 2005 Dec; 289(6):E993-8. PubMed ID: 16030068 [TBL] [Abstract][Full Text] [Related]
35. Proteinuria and plasma compositional changes contribute to defective lipoprotein catabolism in the nephrotic syndrome by separate mechanisms. Shearer GC; Kaysen GA Am J Kidney Dis; 2001 Jan; 37(1 Suppl 2):S119-22. PubMed ID: 11158876 [TBL] [Abstract][Full Text] [Related]
36. The influence of hypoalbuminemia in the generation of nephrotic hyperlipidemia. Joven J; Espinel E; Simó JM; Vilella E; Camps J; Oliver A Atherosclerosis; 1996 Oct; 126(2):243-52. PubMed ID: 8902150 [TBL] [Abstract][Full Text] [Related]
37. Proteinuria, not altered albumin metabolism, affects hyperlipidemia in the nephrotic rat. Davies RW; Staprans I; Hutchison FN; Kaysen GA J Clin Invest; 1990 Aug; 86(2):600-5. PubMed ID: 2384606 [TBL] [Abstract][Full Text] [Related]
38. Candidate genes involved in cardiovascular risk factors by a family-based association study on the island of Kosrae, Federated States of Micronesia. Han Z; Heath SC; Shmulewitz D; Li W; Auerbach SB; Blundell ML; Lehner T; Ott J; Stoffel M; Friedman JM; Breslow JL Am J Med Genet; 2002 Jul; 110(3):234-42. PubMed ID: 12116231 [TBL] [Abstract][Full Text] [Related]
39. The effect of the HMG-CoA reductase inhibitor simvastatin and of cholestyramine on hepatic apolipoprotein mRNA levels in the rat. Mitchell A; Fidge N; Griffiths P Biochim Biophys Acta; 1993 Mar; 1167(1):9-14. PubMed ID: 8461338 [TBL] [Abstract][Full Text] [Related]
40. Hepatic secretion of lipoproteins in the rat and the effect of experimental nephrosis. Marsh JB; Sparks CE J Clin Invest; 1979 Nov; 64(5):1229-37. PubMed ID: 227928 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]